Financhill
Back

UroGen Pharma Vs. Royalty Pharma PLC Industry Stock Comparison

Sell
43

URGN
UroGen Pharma

Last Price:
11.36
Seasonality Move:
5.08%
Sell
32

RPRX
Royalty Pharma PLC

Last Price:
24.85
Seasonality Move:
-2.29%
Sell
43
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy, Sell or Hold?

  • The current UroGen Pharma [URGN] share price is $11.47. The Score for URGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $25.21. The Score for RPRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

  • The UroGen Pharma share price today is $11.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $25.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing selling pressure, which indicates risk of future bearish movement.

URGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 39.41 Sell
Chaikin Money Flow: 14788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 31.98 Sell
Chaikin Money Flow: -901438 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

URGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.05 Sell
20-day SMA: 11.99 Sell
50-day SMA: 12.21 Sell
200-day SMA: 14.16 Sell
8-day EMA: 11.93 Sell
20-day EMA: 12.08 Sell
50-day EMA: 12.39 Sell
200-day EMA: 13.6 Sell

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.84 Sell
20-day SMA: 26.07 Sell
50-day SMA: 26.79 Sell
200-day SMA: 27.74 Sell
8-day EMA: 25.72 Sell
20-day EMA: 26.08 Sell
50-day EMA: 26.62 Sell
200-day EMA: 27.73 Sell

UroGen Pharma Earnings Growth & URGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.22 per share.

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):